e-learning
resources
Madrid 2019
Monday, 30.09.2019
Host-microbe interactions in lung disease and exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2019 - Interleukin-33: a double-edged sword in mast cell responses to rhinovirus infection
C. Banas (Southampton, United Kingdom), C. Akoto (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), E. Swindle (Southampton, United Kingdom)
Source:
International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Session:
Host-microbe interactions in lung disease and exacerbations
Session type:
Thematic Poster
Number:
2388
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Banas (Southampton, United Kingdom), C. Akoto (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), E. Swindle (Southampton, United Kingdom). LSC - 2019 - Interleukin-33: a double-edged sword in mast cell responses to rhinovirus infection. 2388
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
LSC - 2019 - Anti-IL5 in mild asthma alters rhinovirus-induced macrophage, B cell and neutrophil responses
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
LSC - 2020 - IRF5 regulates airway macrophage metabolic responses to viral challenge
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Late Breaking Abstract - The pro-inflammatory activity and role of NLRP3 inflammasome in severe influenza A virus pneumonia.
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Influenza infection of human lung macrophages increases PDL1 expression
Source: Annual Congress 2013 –Viral infections
Year: 2013
LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
LSC - 2020 - The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020
LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Airway epithelial cells from asthmatic adults support elevated human metapneumovirus infection due to impaired apoptosis
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection
Source: Annual Congress 2013 –COPD and infections
Year: 2013
LSC 2010 Abstract: Deficient innate immune antiviral response to infection with rhinoviruses in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LSC Abstract – A novel immune regulatory function of neutrophils in rhinovirus infections
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
Chymase-positive mast cells represent a major source for IL-17A in airway inflammation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept